Biden praises US approval of gene therapies for sickle cell disease

Crispr Therapeutics AG

08/12/2023 21:02

Dec 8 (Reuters) - The U.S. approval of two gene
therapies for sickle cell disease on Friday is a significant
medical advancement that holds "tremendous promise" for
developing additional life-saving treatments, President Joe
Biden said in a statement.
    "My administration will continue our efforts to accelerate
the development of cures for rare diseases and support the
medical research and innovation that achieved this
breakthrough," Biden said in the statement released by the White
House.
    

 (Reporting by Ismail Shakil; editing by Jasper Ward)
 ((ismail.shakil@tr.com;))